Jaber and colleagues 1 report the results of a thoughtfully designed trial examining sodium bicarbonate administration to critically ill adults with acidaemia. We congratulate the authors on this accomplishment and pose two questions.
First, the composite primary outcome chosen by the authors-28-day mortality or an organ failure at day 7-has important limitations. Components of the outcome are assessed at differing timepoints, dysfunction in organ systems mechanistically unrelated to the intervention are included in the composite (eg, haematological dysfunction), and the outcome's relevance to patients is unclear. For phase 3 clinical trials involving acute kidney injury, a National Institute of Diabetes and Digestive and Kidney Diseases work group has recommended as a patient-centred outcome the use of major adverse kidney eventsthe composite of death, new receipt of renal-replacement therapy, or persistent renal dysfunction (defined by plasma creatinine values or glomerular filtration rate).
2,3 Can the authors report what proportion of patients in each study group experienced a major adverse kidney event by 28 days (understanding that the data might be censored at hospital discharge)?
Second, one contributor to acidaemia among critically ill adults is receipt of 0·9% sodium chloride. What volume of intravenous fluid did patients receive before enrolment, and what proportion of that fluid was 0·9% sodium chloride? If bicarbonate administration in the trial was, in part, correcting salineinduced hyperchloremic metabolic acidosis, preferential use of balanced crystalloids for initial resuscitation might diminish the need for, and effect of, subsequent bicarbonate therapy. 4 We declare no competing interests.
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Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA bicarbonate also might have spared saline use and reduced chlorine intake. These two effects would widen the difference in sodium and chlorine concentrations and increase both pH and bicarbonate, which were two of the three indications for dialysis. These criteria were also used more commonly to assess the need for dialysis in the control group than they were in the treatment group and drove the difference in dialysis use ( 28 days became statistically significant (hazard ratio 0·727, 95% CI 0·54-0·98, p=0·035). Because this study was, apparently, the first randomised controlled trial on this treatment, a meta-analysis cannot be done. Therefore, we need larger trials to clearly identify the effect (or lack of it) of sodium bicarbonate in patients with severe metabolic acidaemia.
I declare no competing interests. 4 The only effect of sodium bicarbonate that Jaber and colleagues found was decreased use of dialysis, which could have clinical value.
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5 But was dialysis necessary in all cases? In the physical and chemical analysis of acid-base abnormalities developed by Peter Stewart, 6,7 the difference in sodium and chlorine concentrations is a crucial determinant of pH and bicarbonite concentration. When sodium bicarbonate is given, the strong sodium ion remains free and carbon dioxide and bicarbonate are controlled by ventilation. Consistent with this process, mean carbon dioxide concentration did not change in Jaber and colleagues' study, 1 although the mean might have changed in patients with fixed ventilation. Use of sodium
